Upregulation of the Intestinal Paracellular Pathway with Breakdown of Tight and Adherens Junctions in Deficit Schizophrenia

[1]  M. Maes,et al.  In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde , 2020, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[2]  M. Maes,et al.  The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia , 2019, Molecular Neurobiology.

[3]  C. Noto,et al.  Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis , 2019, European Neuropsychopharmacology.

[4]  M. Maes,et al.  A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions. , 2019, CNS & neurological disorders drug targets.

[5]  D. Jeste,et al.  Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects , 2019, Schizophrenia Research.

[6]  Juan-Gabriel Cegarra-Navarro,et al.  Tips to use partial least squares structural equation modelling (PLS-SEM) in knowledge management , 2019, J. Knowl. Manag..

[7]  M. Maes,et al.  In Schizophrenia, Increased Plasma IgM/IgA Responses to Gut Commensal Bacteria Are Associated with Negative Symptoms, Neurocognitive Impairments, and the Deficit Phenotype , 2018, Neurotoxicity Research.

[8]  M. Maes,et al.  In Schizophrenia, Deficits in Natural IgM Isotype Antibodies Including those Directed to Malondialdehyde and Azelaic Acid Strongly Predict Negative Symptoms, Neurocognitive Impairments, and the Deficit Syndrome , 2018, Molecular Neurobiology.

[9]  A. Carvalho,et al.  The role of aberrations in the immune-inflammatory reflex system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia Short title: The IRS-CIRS theory of schizophrenia , 2018 .

[10]  M. Maes,et al.  Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients , 2018, Neurotoxicity Research.

[11]  M. Maes,et al.  The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder , 2018, Molecular Neurobiology.

[12]  M. Maes,et al.  Body image dissatisfaction in pregnant and non-pregnant females is strongly predicted by immune activation and mucosa-derived activation of the tryptophan catabolite (TRYCAT) pathway , 2018, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[13]  M. Maes,et al.  In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study , 2018, Neurotoxicity Research.

[14]  M. Maes,et al.  Natural regulatory IgM‐mediated autoimmune responses directed against malondialdehyde regulate oxidative and nitrosative pathways and coupled with IgM responses to nitroso adducts attenuate depressive and physiosomatic symptoms at the end of term pregnancy , 2018, Psychiatry and clinical neurosciences.

[15]  P. Tyrrell,et al.  Haptoglobin 2-2 genotype is associated with presence and progression of MRI depicted atherosclerotic intraplaque hemorrhage , 2017, International journal of cardiology. Heart & vasculature.

[16]  Can Ergün,et al.  A review on the relationship between gluten and schizophrenia: Is gluten the cause? , 2017, Nutritional neuroscience.

[17]  S. Hemrungrojn,et al.  Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia , 2017, Molecular Neurobiology.

[18]  M. Geffard,et al.  Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid , 2017, Molecular Neurobiology.

[19]  Zahiruddin Othman,et al.  Lipopolysaccharide-induced memory impairment in rats: a model of Alzheimer's disease. , 2017, Physiological research.

[20]  S. A. Wijtenburg,et al.  Antigliadin Antibodies (AGA IgG) Are Related to Neurochemistry in Schizophrenia , 2017, Front. Psychiatry.

[21]  S. Bogdan,et al.  Adherens Junctions on the Move-Membrane Trafficking of E-Cadherin. , 2017, Cold Spring Harbor perspectives in biology.

[22]  M. Geffard,et al.  IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome , 2016, Molecular Neurobiology.

[23]  U. de Faire,et al.  Human IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60‐Year‐Olds , 2016, Journal of the American Heart Association.

[24]  Arunima Chaudhuri,et al.  Bacterial outer membrane vesicles: New insights and applications , 2016, Molecular membrane biology.

[25]  M. McMahon,et al.  Autoimmunity: Do IgM antibodies protect against atherosclerosis in SLE? , 2016, Nature Reviews Rheumatology.

[26]  C. Pantelis,et al.  A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis , 2016, Neuroscience & Biobehavioral Reviews.

[27]  B. Boehm,et al.  The haptoglobin 2-2 genotype is associated with inflammation and carotid artery intima-media thickness , 2016, Diabetes & vascular disease research.

[28]  Ping Wang,et al.  The role of B-1 cells in inflammation , 2015, Immunologic research.

[29]  P. Ostoa-Saloma,et al.  Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (Review) , 2015, Oncology reports.

[30]  G. Perilongo,et al.  Gut microbiota-derived outer membrane vesicles: under-recognized major players in health and disease? , 2015, Discovery medicine.

[31]  Guillermo A. Gomez,et al.  An RPTPα/Src family kinase/Rap1 signaling module recruits myosin IIB to support contractile tension at apical E-cadherin junctions , 2015, Molecular biology of the cell.

[32]  Lai Guan Ng,et al.  The gut microbiota influences blood-brain barrier permeability in mice , 2014, Science Translational Medicine.

[33]  M. Maes,et al.  Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries , 2014, The Australian and New Zealand journal of psychiatry.

[34]  Dirceu da Silva,et al.  Structural Equation Modeling with the SmartPLS , 2014 .

[35]  M. Rodríguez-Moran,et al.  Haptoglobin 2-2 Genotype Is Associated with TNF-α and IL-6 Levels in Subjects with Obesity , 2014, Disease markers.

[36]  D. Ye,et al.  Interleukin-6 Modulation of Intestinal Epithelial Tight Junction Permeability Is Mediated by JNK Pathway Activation of Claudin-2 Gene , 2014, PloS one.

[37]  Mónica Díaz-Coránguez,et al.  Tight Junctions , 2022 .

[38]  H. Kaku,et al.  Human B‐1 cells take the stage , 2013, Annals of the New York Academy of Sciences.

[39]  Michael Maes,et al.  Role of the Toll Like Receptor (TLR) Radical Cycle in Chronic Inflammation: Possible Treatments Targeting the TLR4 Pathway , 2013, Molecular Neurobiology.

[40]  C. Binder,et al.  The innate immune response to products of phospholipid peroxidation☆ , 2012, Biochimica et biophysica acta.

[41]  A. Fasano.  Zonulin, regulation of tight junctions, and autoimmune diseases , 2012, Annals of the New York Academy of Sciences.

[42]  G. Silverman,et al.  Protective Roles of Natural IgM Antibodies , 2012, Front. Immun..

[43]  C. Binder.  Naturally occurring IgM antibodies to oxidation-specific epitopes. , 2012, Advances in experimental medicine and biology.

[44]  A. Fasano.  Leaky Gut and Autoimmune Diseases , 2012, Clinical Reviews in Allergy & Immunology.

[45]  P. Cummins.  Occludin: One Protein, Many Forms , 2011, Molecular and Cellular Biology.

[46]  Roberto Dominguez,et al.  Actin structure and function. , 2011, Annual review of biophysics.

[47]  M. Kuehn,et al.  Naturally Produced Outer Membrane Vesicles from Pseudomonas aeruginosa Elicit a Potent Innate Immune Response via Combined Sensing of Both Lipopolysaccharide and Protein Components , 2010, Infection and Immunity.

[48]  M. Geffard,et al.  Circulating Antibodies to IDO/THO Pathway Metabolites in Alzheimer's Disease , 2010, International journal of Alzheimer's disease.

[49]  M. Kuehn,et al.  Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles , 2010, Microbiology and Molecular Biology Reviews.

[50]  R. Mennigen,et al.  Endocytosis and Recycling of Tight Junction Proteins in Inflammation , 2009, Journal of biomedicine & biotechnology.

[51]  J. Turner,et al.  The tight junction in inflammatory disease: communication breakdown. , 2009, Current opinion in pharmacology.

[52]  Takuya Suzuki,et al.  Phosphorylation of Tyr-398 and Tyr-402 in Occludin Prevents Its Interaction with ZO-1 and Destabilizes Its Assembly at the Tight Junctions* , 2009, Journal of Biological Chemistry.

[53]  Takuya Suzuki,et al.  PKCη regulates occludin phosphorylation and epithelial tight junction integrity , 2009, Proceedings of the National Academy of Sciences.

[54]  M. Boivin,et al.  Mechanism of cytokine modulation of epithelial tight junction barrier. , 2009, Frontiers in bioscience.

[55]  G. Berx,et al.  The cell-cell adhesion molecule E-cadherin , 2008, Cellular and Molecular Life Sciences.

[56]  W. Nelson,et al.  Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. , 2008, Biochimica et biophysica acta.

[57]  M. Maes,et al.  The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. , 2008, Neuro endocrinology letters.

[58]  M. Maes,et al.  Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. , 2007, Journal of affective disorders.

[59]  A. Nusrat,et al.  Inflammatory Bowel Disease and the Apical Junctional Complex , 2006, Annals of the New York Academy of Sciences.

[60]  R. D. Lynch,et al.  Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. , 2005, American journal of physiology. Cell physiology.

[61]  P. Kittirattanapaiboon,et al.  The Validity of the Mini International Neuropsychiatric Interview (M.I.N.I)-Thai version , 2005 .

[62]  H. Zhu,et al.  Abnormal changes of plasma acute phase proteins in schizophrenia and the relation between schizophrenia and haptoglobin (Hp) gene , 2005, Amino Acids.

[63]  L. Arnould,et al.  Identification d’anticorps circulant dans le sérum de patientes porteuses de tumeurs malignes du sein , 2003 .

[64]  C. Gottfries,et al.  A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale). , 2002, Journal of psychosomatic research.

[65]  M. Jensen,et al.  Anti-S-Nitrosocysteine Antibodies Are a Predictive Marker for Demyelination in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis , 2002, The Journal of Neuroscience.

[66]  R. Pioli,et al.  Haptoglobin polymorphism and schizophrenia: Genetic variation on chromosome 16 , 2001, Psychiatry Research.

[67]  J. Wolff,et al.  Specific recognition of protein carboxy-terminal sequences by natural IgM antibodies in normal serum. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[68]  M. Mori,et al.  Occludin regulates actin cytoskeleton in endothelial cells. , 2001, Cell structure and function.

[69]  T. Noda,et al.  Complex phenotype of mice lacking occludin, a component of tight junction strands. , 2000, Molecular biology of the cell.

[70]  M. Balda,et al.  Transmembrane proteins of tight junctions. , 2000, Seminars in cell & developmental biology.

[71]  R. D. Lynch,et al.  Occludin is a functional component of the tight junction. , 1996, Journal of cell science.

[72]  M. Balda,et al.  Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical- basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein , 1996, The Journal of cell biology.

[73]  M. Geffard,et al.  Circulating antibodies directed against conjugated fatty acids in sera of patients with multiple sclerosis , 1996, Journal of Neuroimmunology.

[74]  G. Scarlato,et al.  Anti-alpha- and beta-tubulin IgM antibodies in dysimmune neuropathies , 1995, Journal of the Neurological Sciences.

[75]  M. Geffard,et al.  Autoantibodies to malondialdehyde‐modified epitope in connective tissue diseases and vasculitides , 1995, Clinical and experimental immunology.

[76]  R. S. Smith,et al.  The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. , 1995, Medical hypotheses.

[77]  M. Geffard,et al.  Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine , 1995, Journal of Neuroimmunology.

[78]  M. Itoh,et al.  Occludin: a novel integral membrane protein localizing at tight junctions , 1993, The Journal of cell biology.

[79]  M. Geffard,et al.  Anti-phosphoinositide auto-antibodies in sera of cancer patients: isotypic and immunochemical characterization. , 1992, Cancer letters.

[80]  N. Andreasen.  The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and Theoretical Foundations , 1989, British Journal of Psychiatry.

[81]  Robert W. Buchanan,et al.  The schedule for the deficit syndrome: An instrument for research in schizophrenia , 1989, Psychiatry Research.

[82]  M. Geffard,et al.  Identification and characterization of anti-conjugated azelaic acid antibodies in multiple sclerosis , 1989, Journal of Neuroimmunology.

[83]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[84]  K. Burridge,et al.  Talin: a cytoskeletal component concentrated in adhesion plaques and other sites of actin-membrane interaction. , 1983, Cell motility.

[85]  F. Dohan,et al.  Relapsed schizophrenics: earlier discharge from the hospital after cereal-free, milk-free diet. , 1973, The American journal of psychiatry.

[86]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[87]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[88]  M. Hamilton.  The assessment of anxiety states by rating. , 1959, The British journal of medical psychology.